Financial Architects (New Jersey)’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-500
| Closed | -$1K | – | 849 |
|
|
2020
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 836 |
|
|
2020
Q1 | $1K | Hold |
500
| – | – | ﹤0.01% | 835 |
|
|
2019
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 859 |
|
|
2019
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 971 |
|
|
2019
Q2 | $2K | Sell |
500
-3,000
| -86% | -$12K | ﹤0.01% | 1001 |
|
|
2019
Q1 | $13K | Hold |
3,500
| – | – | ﹤0.01% | 922 |
|
|
2018
Q4 | $10K | Hold |
3,500
| – | – | ﹤0.01% | 901 |
|
|
2018
Q3 | $9K | Hold |
3,500
| – | – | ﹤0.01% | 1012 |
|
|
2018
Q2 | $8K | Hold |
3,500
| – | – | ﹤0.01% | 1061 |
|
|
2018
Q1 | $10K | Hold |
3,500
| – | – | ﹤0.01% | 965 |
|
|
2017
Q4 | $9K | Hold |
3,500
| – | – | ﹤0.01% | 1058 |
|
|
2017
Q3 | $12K | Hold |
3,500
| – | – | ﹤0.01% | 998 |
|
|
2017
Q2 | $8K | Hold |
3,500
| – | – | ﹤0.01% | 1088 |
|
|
2017
Q1 | $8K | Hold |
3,500
| – | – | ﹤0.01% | 1098 |
|
|
2016
Q4 | $7K | Hold |
3,500
| – | – | ﹤0.01% | 1091 |
|
|
2016
Q3 | $12K | Hold |
3,500
| – | – | ﹤0.01% | 952 |
|
|
2016
Q2 | $11K | Buy |
3,500
+3,000
| +600% | +$9.43K | ﹤0.01% | 951 |
|
|
2016
Q1 | $2K | Buy |
+500
| New | +$2K | ﹤0.01% | 1081 |
|
|
2015
Q3 | – | Sell |
-500
| Closed | -$3K | – | 1179 |
|
|
2015
Q2 | $3K | Buy |
+500
| New | +$3K | ﹤0.01% | 1047 |
|
|
2015
Q1 | – | Sell |
-500
| Closed | -$4K | – | 1080 |
|
|
2014
Q4 | $4K | Hold |
500
| – | – | ﹤0.01% | 870 |
|
|
2014
Q3 | $4K | Hold |
500
| – | – | ﹤0.01% | 772 |
|
|
2014
Q2 | $5K | Buy |
+500
| New | +$5K | ﹤0.01% | 777 |
|